Table 1 Baseline patient characteristics relative to chemoprophylaxis use
Variable | Overall (n = 316) | Given chemoprophylaxis | p value | |
|---|---|---|---|---|
Yes (n = 117) | No (n = 199) | |||
Age (years) | < 0.001*** | |||
Mean | 65.3 | 67.5 | 63.9 | |
Median | 65.0 | 67.0 | 64.0 | |
SD | 8.5 | 8.5 | 8.3 | |
Range | 41–88 | 47–88 | 41–83 | |
Gender | 0.596 | |||
Female | 227 (71.8%) | 82 (70.1%) | 145 (72.9%) | |
Male | 89 (28.2%) | 35 (29.9%) | 54 (27.1%) | |
BMI | 0.016* | |||
Mean | 28.7 | 27.7 | 29.3 | |
Median | 28.6 | 27.5 | 29.0 | |
SD | 5.6 | 4.8 | 5.9 | |
Range | 16.6–51.1 | 18.30–51.10 | 16.60–45.20 | |
Obesity (BMI > 30) | < 0.001*** | |||
Yes | 101 (34.6%) | 23 (21.3%) | 78 (42.4%) | |
No | 191 (65.4%) | 85 (78.7%) | 106 (57.6%) | |
Hypertension | 0.821 | |||
Yes | 197 (62.3%) | 72 (61.5%) | 125 (62.8%) | |
No | 119 (37.7%) | 45 (38.5%) | 74 (37.2%) | |
Hyperlipidemia | 0.402 | |||
Yes | 174 (55.1%) | 68 (58.1%) | 106 (53.3%) | |
No | 142 (44.9%) | 49 (41.9%) | 93 (46.7%) | |
Diabetes mellitus | 0.382 | |||
Yes | 79 (25.0%) | 26 (22.2%) | 53 (26.6%) | |
No | 237 (75.0%) | 91 (77.8%) | 146 (73.4%) | |
Ischemic heart disease | < 0.001*** | |||
Yes | 42 (13.3%) | 28 (23.9%) | 14 (7.0%) | |
No | 274 (86.7%) | 89 (76.1%) | 185 (93.0%) | |
History of cancer | 0.787 | |||
Yes | 12 (3.8%) | 4 (3.4%) | 8 (4.0%) | |
No | 304 (96.2%) | 113 (96.6%) | 191 (96.0%) | |